¼¼°èÀÇ ½ÊÀÌÁöÀå±Ë¾ç Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Duodenal Ulcer Treatment Global Market Report 2025
»óǰÄÚµå : 1704184
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,692,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

½ÊÀÌÁöÀå±Ë¾ç Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸À̸ç 2029³â±îÁö ¿¬Æò±Õ 7.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 1,428¾ï 2,200¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ ÁßÀÇ ¼ºÀåÀº Áúº´ ¼ö Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó ¹× ÀÇ·á ½Ã¼³ Áõ°¡, Ä¡·á ¿É¼ÇÀÇ °¡¿ë¼º¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÃÖ¼Ò Ä§½ÀÀû ½Ã¼ú¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, Á¤ºÎÀÇ ÀÎ½Ä È®»ê ³ë·Â Áõ°¡ µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¿¹Ãø ±â°£ Áß ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ±â¼ú ¹ßÀü, ÇÁ·Î¹ÙÀÌ¿Àƽ½º ÅëÇÕ, ¿ø°ÝÀÇ·á, ¿µ¾ç ¿ä¹ý, ±Ù°Å ±â¹Ý Áø·áÀÇ ÅëÇÕ µîÀÌ ÀÖ½À´Ï´Ù.

½ÊÀÌÁöÀå±Ë¾ç Ä¡·áÁ¦ ½ÃÀåÀÇ ¼ºÀåÀÌ ¿¹ÃøµÇ´Â ¹è°æ¿¡´Â ´ã¹è¸¦ ÇÇ¿ì´Â »ç¶÷ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±È·ÃÇü ÀüÀÚ´ã¹è´Â ´ã¹è°¡ ´ã±ä ÀÛÀº Á¾À̸¦ ¸»¾Æ¼­ ¿¬±â¸¦ µéÀ̸¶½Ã°Å³ª ³»»ÕÀ¸¸ç ÇÇ¿ì´Â ´ã¹è¸¦ ¸»ÇÕ´Ï´Ù. Èí¿¬ÀÚ Áõ°¡´Â ¹®È­Àû ¿äÀÎ, °ø°øÁ¤Ã¥, »çȸ°æÁ¦Àû Á¶°ÇÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. Èí¿¬ÀÚÀÇ ½ÊÀÌÁöÀå±Ë¾ç Ä¡·á¿¡´Â ±Ë¾ç¿¡ ƯȭµÈ Ä¡·á, ±Ý¿¬ ÇÁ·Î±×·¥, »ýȰ½À°ü °³¼±, Ä¡À¯¸¦ ÃËÁøÇϰí Àç¹ßÀ» ¿¹¹æÇϱâ À§ÇÑ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ µî öÀúÇÑ Á¢±ÙÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¿¹¸¦ µé¾î ¿µ±¹ Åë°èû ÀÚ·á¿¡ µû¸£¸é 2022³â 18¼¼ ÀÌ»ó ¼ºÀÎ Áß ¾à 640¸¸ ¸íÀÌ ´ã¹è¸¦ ÇÇ¿ì°í ÀÖÀ¸¸ç, ÀÌ´Â Àüü Àα¸ÀÇ 12.9%¿¡ ÇØ´çÇÕ´Ï´Ù. ¶ÇÇÑ 16¼¼¿¡¼­ 24¼¼ ¿¬·ÉÃþ¿¡¼­ ÀüÀÚ´ã¹è »ç¿ë·üÀº 2021³â 11.1%¿¡¼­ 2022³â 15.5%·Î »ó½ÂÇß½À´Ï´Ù. ÀÌ·¯ÇÑ Èí¿¬À² Áõ°¡´Â ½ÊÀÌÁöÀå±Ë¾ç Ä¡·á ½ÃÀåÀÇ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÊÀÌÁöÀå±Ë¾ç Ä¡·á ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ½ÊÀÌÁöÀå±Ë¾ç°ú Ç︮ÄÚ¹ÚÅÍ ÆÄÀϷθ®±Õ °¨¿°À» µ¿½Ã¿¡ Ä¡·áÇÏ´Â ÄÞºñ³×ÀÌ¼Ç Å°Æ®¿Í °°ÀÌ ±Ë¾ç Ä¡À¯¸¦ °³¼±Çϱâ À§ÇÑ Ã·´Ü Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÄÞºñ³×ÀÌ¼Ç Å°Æ®´Â ÀϹÝÀûÀ¸·Î ±Ë¾ç Ä¡À¯¿Í Ç︮ÄÚ¹ÚÅÍ ÆÄÀϷθ®±Õ Á¦±ÕÀ» ¸ñÀûÀ¸·Î ÇÏ´Â ¾à¹°À» Æ÷ÇÔÇÏ´Â Ä¡·á¹ýÀÔ´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 4¿ù Àεµ Á¦¾à»ç Akums Drugs and Pharmaceutical Limited´Â Ç︮ÄÚ¹ÚÅÍ ÆÄÀϷθ®±Õ °¨¿°°ú °ü·ÃµÈ ½ÊÀÌÁöÀå±Ë¾çÀ» À§ÇÑ Çõ½ÅÀûÀÎ Á¶ÇÕ Å°Æ®¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ Å°Æ®´Â ¾Æ¸ñ½Ã½Ç¸°, Ŭ¶ó¸®½º·Î¸¶À̽Å, ¿¡¼Ò¸ÞÇÁ¶óÁ¹ÀÇ ¼¼ °¡Áö È¿°úÀûÀÎ ¾à¹°À» °áÇÕÇÏ¿© Ç︮ÄÚ¹ÚÅÍ ÆÄÀϷθ®±Õ°ú ½Î¿ì°í À§»ê ºÐºñ¸¦ °¨¼Ò½ÃÅ´À¸·Î½á ½ÊÀÌÁöÀå±Ë¾çÀÇ ÁÖ¿ä ¿øÀο¡ ´ëóÇÕ´Ï´Ù. Áß¾Ó ÀǾàǰ Ç¥Áذü¸®±â±¸(CDSCO)´Â ÀÌ Å°Æ®¸¦ Ȱµ¿¼º ¶Ç´Â ¿ÏÄ¡µÈ ¼ÒÈ­¼º ±Ë¾ç ȯÀÚÀÇ ½ÊÀÌÁöÀå±Ë¾ç Ä¡·á ¹× Ç︮ÄÚ¹ÚÅÍ ÆÄÀϷθ®±Õ Á¦±Õ¿¡ »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ½ÂÀÎÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀåÀÇ Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª¹ÙÀÌ·¯½º ¹× °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ´ë±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÇÕº´°ú Àμö

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Duodenal ulcer treatment encompasses the methods used to heal and manage ulcers located in the duodenum, the initial segment of the small intestine. This treatment typically includes a mix of medications aimed at decreasing acid production and fostering healing, lifestyle modifications, and occasionally, treatments to eliminate Helicobacter pylori bacteria, which is a frequent cause of duodenal ulcers.

The primary treatment options for duodenal ulcers are antibiotics, proton pump inhibitors, antacids, potassium-competitive acid blockers, H2-antagonists, ulcer-protective drugs, and surgery. Antacids are specifically used to address bacterial infections such as those caused by Helicobacter pylori, which can contribute to the development of duodenal ulcers. This aids in eradicating the bacterial infection and facilitating proper ulcer healing. These treatments are applicable to both adults and the elderly, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The duodenal ulcer treatment market research report is one of a series of new reports from The Business Research Company that provides duodenal ulcer treatment market statistics, including duodenal ulcer treatment industry global market size, regional shares, competitors with a duodenal ulcer treatment market share, detailed duodenal ulcer treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the duodenal ulcer treatment industry. This duodenal ulcer treatment research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The duodenal ulcer treatment market size has grown strongly in recent years. It will grow from $99.99 billion in 2024 to $107.67 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increased patient preference for non-invasive treatments, growth in gastrointestinal health awareness, increase in the number of cigarette smokers, increase in the number of alcohol or tobacco consumers, and increase in the integration of digital health solutions.

The duodenal ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $142.82 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing number of diseases, an increasing number of medical infrastructure and healthcare facilities, growing awareness about the availability of treatment options, growing preference for minimally invasive procedures, and increasing efforts to spread awareness by the government. Major trends in the forecast period include technological advancements, integration of probiotics, telemedicine, nutritional therapy, and evidence-based practice integration.

The anticipated growth in the duodenal ulcer treatment market is linked to the rising number of cigarette smokers. Cigarette smokers are individuals who regularly consume cigarettes, which are small rolls of paper filled with tobacco that are smoked by inhaling and exhaling the smoke. The rise in cigarette smoking is influenced by cultural factors, public policies, and socioeconomic conditions. Managing duodenal ulcers in smokers requires a thorough approach, including ulcer-specific treatments, smoking cessation programs, lifestyle changes, and continuous monitoring to promote healing and prevent recurrence. For example, data from the Office for National Statistics in the UK revealed that in 2022, approximately 6.4 million adults over 18 were cigarette smokers, representing 12.9% of the population. Additionally, among the 16 to 24 age group, e-cigarette use rose to 15.5% in 2022, up from 11.1% in 2021. This increase in smoking rates is contributing to the expansion of the duodenal ulcer treatment market.

Key players in the duodenal ulcer treatment market are concentrating on creating advanced products, such as combination kits for treating both duodenal ulcers and H. pylori infections, to improve ulcer healing. A combination kit generally involves a therapy that includes medications designed to heal the ulcer and eliminate the H. pylori bacteria. For example, in April 2023, Akums Drugs and Pharmaceutical Limited, an Indian pharmaceutical company, introduced an innovative combination kit for duodenal ulcers related to H. pylori infection. This kit combines three effective medications-amoxicillin, clarithromycin, and esomeprazole-to combat H. pylori bacteria and decrease gastric acid production, addressing the main causes of duodenal ulcers. The Central Drugs Standard Control Organization (CDSCO) has approved this kit for treating duodenal ulcers and eliminating H. pylori in patients with active or healed peptic ulcers.

In June 2022, Glenmark Pharmaceuticals Ltd., an Indian company specializing in duodenal ulcer treatments, acquired over-the-counter (OTC) drug products from Wockhardt Limited for an undisclosed sum. This acquisition highlights Glenmark's ongoing efforts to expand in the US OTC market and demonstrates its dedication to providing affordable, high-quality medications. Wockhardt Limited, also based in India, is a pharmaceutical and biotechnology company that offers treatments for duodenal ulcers.

Major companies operating in the duodenal ulcer treatment market are Pfizer Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz AG, Sun Pharmaceutical Industries Limited, Eisai Co. Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Limited, Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Limited, Alkem Laboratories Limited, Jubilant Pharma Limited, Torrent Pharmaceuticals Limited

North America was the largest region in the duodenal ulcer treatment market in 2024. The regions covered in the duodenal ulcer treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the duodenal ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The duodenal ulcer treatment market consists of revenues earned by entities by providing services such as endoscopic therapies, follow-up care, and lifestyle and dietary changes. The market value includes the value of related goods sold by the service provider or included within the service offering. The duodenal ulcer treatment market also includes sales of endoscopic devices, surgical instruments, H2-receptor antagonists, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Duodenal Ulcer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on duodenal ulcer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for duodenal ulcer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The duodenal ulcer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Duodenal Ulcer Treatment Market Characteristics

3. Duodenal Ulcer Treatment Market Trends And Strategies

4. Duodenal Ulcer Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Duodenal Ulcer Treatment Growth Analysis And Strategic Analysis Framework

6. Duodenal Ulcer Treatment Market Segmentation

7. Duodenal Ulcer Treatment Market Regional And Country Analysis

8. Asia-Pacific Duodenal Ulcer Treatment Market

9. China Duodenal Ulcer Treatment Market

10. India Duodenal Ulcer Treatment Market

11. Japan Duodenal Ulcer Treatment Market

12. Australia Duodenal Ulcer Treatment Market

13. Indonesia Duodenal Ulcer Treatment Market

14. South Korea Duodenal Ulcer Treatment Market

15. Western Europe Duodenal Ulcer Treatment Market

16. UK Duodenal Ulcer Treatment Market

17. Germany Duodenal Ulcer Treatment Market

18. France Duodenal Ulcer Treatment Market

19. Italy Duodenal Ulcer Treatment Market

20. Spain Duodenal Ulcer Treatment Market

21. Eastern Europe Duodenal Ulcer Treatment Market

22. Russia Duodenal Ulcer Treatment Market

23. North America Duodenal Ulcer Treatment Market

24. USA Duodenal Ulcer Treatment Market

25. Canada Duodenal Ulcer Treatment Market

26. South America Duodenal Ulcer Treatment Market

27. Brazil Duodenal Ulcer Treatment Market

28. Middle East Duodenal Ulcer Treatment Market

29. Africa Duodenal Ulcer Treatment Market

30. Duodenal Ulcer Treatment Market Competitive Landscape And Company Profiles

31. Duodenal Ulcer Treatment Market Other Major And Innovative Companies

32. Global Duodenal Ulcer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Duodenal Ulcer Treatment Market

34. Recent Developments In The Duodenal Ulcer Treatment Market

35. Duodenal Ulcer Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â